Jamie Smith
Communications médias
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke Health Care unveils new headquarters at GoCo Health Innovation City, marking a new era of collaboration and innovation
Gothenburg, Sweden, 5 March 2025. Mölnlycke Health Care has now established the new headquarters at GoCo Health Innovation City in the Gothenburg region of Sweden. GoCo is a Life Science knowledge hub that brings together companies, scientists, entrepreneurs, health care providers and talent from around the world. The move underscores Mölnlycke's commitment to embracing partnerships and fostering collaboration to drive the health innovations of tomorrow.
“Placing Mölnlycke together with other key players in Life Science is a game-changer. It opens up entirely new possibilities for us to collaborate with experts from various disciplines, and the chance to practice what we preach: embracing partnerships”, says Zlatko Rihter, CEO of Mölnlycke. “Relocating to this new site is a leap forward for Mölnlycke, preparing us for the future with an office designed to meet the new demands of a workplace.”
Investing in a new headquarters as a founding partner at GoCo Health Innovation City provides a unique opportunity to shape and put Gothenburg’s leading MedTech cluster on the map to help revolutionise care. The move reinforces Mölnlycke's strong commitment to Gothenburg, Sweden, and dedication to continue being an attractive employer in the region and beyond.
The state-of-the-art building features significantly improved collaborative spaces, making it easy for everyone to collaborate and socialise with colleagues, customers, and partners. The new headquarters provides three times more capacity for research and development teams compared to before, making room for innovations that can revolutionise care for people and planet.
-Ends-
For more information, please contact:
Dernières nouvelles
-
High burnout among operating room staff poses significant risk to patient safety—new review reveals
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.
-
New study highlights the importance of double gloving with indicator systems
A new peer-reviewed study published in the Journal of Hospital Infection underscores the critical role of double gloving and indicator systems in reducing the risk of undetected glove breaches during surgery.
-
Mölnlycke Health Care secures USD 400 Million in financing from SEK to support global expansion strategy
Stockholm/Gothenburg – 24 June, 2025. Mölnlycke Health Care and The Swedish Export Credit Corporation (SEK) have signed a USD 400 million financing agreement to support the healthcare company’s continued global growth and development.
-
Mölnlycke Health Care inaugurates new global headquarters at GoCo Health Innovation City
Gothenburg, Sweden. 21 May 2025 – Mölnlycke Health Care, a global leader in MedTech, has officially opened its new global headquarters at GoCo Health Innovation City in Gothenburg, Sweden—a major milestone in its journey to drive sustainable healthcare innovation.
-
Mölnlycke advocates a holistic approach to healthcare sustainability
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.
-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke Health Care’s long-term target to reach net zero emissions validated by Science Based Targets initiative
Gothenburg, Sweden. 13 May, 2025. Mölnlycke’s long-term net zero greenhouse gas (GHG) emission reduction targets have been validated by the Science Based Targets initiative (SBTi), following prior validation of the company’s near-term GHG emission reduction targets.
-
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% to 60% to become majority shareholder in Tamer Mölnlycke Care - a joint venture with Tamer Group, the market leader in healthcare distribution in the Kingdom of Saudi Arabia.
-
Mölnlycke Health Care agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturizing.